BridgeMD
New treatment option for Facioscapulohumeral Dystrophy
Official title Walking ANalysis Interest in Persons wiTh facioscapulohumEral Muscular Dystrophies
ClinicalTrials.gov ID: NCT06600308
What this study is testing
- What it's testing
- Facioscapulohumeral muscular dystrophy (FSH) is one of the most common genetic myopathies in adults. It is characterised by progressive asymmetric muscular atrophy affecting the skeletal muscles of the face, upper limbs and then lower limbs, causing problems with walking, which is one of the most frequent complaints of these patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient :
- Adult ;
- Having given written consent;
- With an established molecular genetic diagnosis of FSH;
- Able to understand the instructions for carrying out the various tests;
You likely can't join if
- Patient :
- Not affiliated to or not benefiting from a social security scheme;
- With one or more cardiorespiratory contraindications to a 6-minute test;
- With another neuro-orthopaedic history (other than FSH) that could significantly compromise walking ability;
- With cognitive problems preventing them from performing standardised tasks;
- Under legal protection (curatorship, guardianship).
See the full eligibility criteria
- Patient :
- Adult ;
- Having given written consent;
- With an established molecular genetic diagnosis of FSH;
- Able to understand the instructions for carrying out the various tests;
- Able to walk for at least 6 minutes, even intermittently;
- Patient :
- Not affiliated to or not benefiting from a social security scheme;
- With one or more cardiorespiratory contraindications to a 6-minute test;
- With another neuro-orthopaedic history (other than FSH) that could significantly compromise walking ability;
- With cognitive problems preventing them from performing standardised tasks;
- Under legal protection (curatorship, guardianship).
- Who are subject to a legal protection measure;
- Pregnant, parturient or breast-feeding woman;
- Unable to benefit from longitudinal follow-up (D15 and M6).
The study team makes the final eligibility decision.
Where it's taking place
- Dijon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dijon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.